Unique ID issued by UMIN | UMIN000029320 |
---|---|
Receipt number | R000033497 |
Scientific Title | Immune function analysis after sirolimus treatment for pediatric patients with intractable vascular anomalies |
Date of disclosure of the study information | 2017/09/29 |
Last modified on | 2017/09/27 22:51:40 |
Immune function analysis after sirolimus treatment for pediatric patients with intractable vascular anomalies
Immune function analysis after sirolimus treatment for pediatric patients with intractable vascular anomalies
Immune function analysis after sirolimus treatment for pediatric patients with intractable vascular anomalies
Immune function analysis after sirolimus treatment for pediatric patients with intractable vascular anomalies
Japan |
Intractable vascular anomalies
Medicine in general | Hepato-biliary-pancreatic medicine | Pneumology |
Hematology and clinical oncology | Neurology | Surgery in general |
Hepato-biliary-pancreatic surgery | Vascular surgery | Chest surgery |
Pediatrics | Dermatology | Oto-rhino-laryngology |
Orthopedics | Radiology | Oral surgery |
Neurosurgery | Plastic surgery | Aesthetic surgery |
Others
NO
To investigate immune function analysis after sirolimus treatment for the Japanese pediatric patients
Others
To research the association between the sirolimus treatment and infection frequency
Immune function analysis after sirolimus treatment for the Japanese pediatric patients
The association between the sirolimus treatment and infection frequency
Observational
Not applicable |
Not applicable |
Male and Female
Intractable vascular anomalies
1. Patients with a history of hypersensitivity to ingredients of this drug
2. Patients with serious liver and renal disorders
3. Patients with symptoms that affect cytokine value of such obvious infection at the time of specimen collection
4. Patients must also avoid strong inducers of CYP3A4
5. Past usage of mTOR inhibitors or other molecular target drugs relating mTOR pathway
6. Patient who is judged inappropriate to participate in this study by the investigators
10
1st name | |
Middle name | |
Last name | Michio Ozeki |
Gifu University Hospital
The department of Pediatrics
1-1 Yanagito, Gifu-shi, Gifu-ken
058-230-6000
michioo@gifu-u.ac.jp
1st name | |
Middle name | |
Last name | Michio Ozeki |
Gifu University Hospital
The department of Pediatrics
1-1 Yanagito, Gifu-shi, Gifu-ken
058-230-6000
michioo@gifu-u.ac.jp
Gifu University
Japan Agency for Medical Research and Development
Japanese Governmental office
NO
(国立成育医療研究センター(東京都)、慶應義塾大学病院(東京都)、京都府立医科大学附属病院(京都)、九州大学病院(福岡県)、浜松医科大学(静岡県)
2017 | Year | 09 | Month | 29 | Day |
Unpublished
Enrolling by invitation
2017 | Year | 08 | Month | 20 | Day |
2017 | Year | 08 | Month | 20 | Day |
For more information, please contact the Principal Investigator.
2017 | Year | 09 | Month | 27 | Day |
2017 | Year | 09 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033497
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |